欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号BE/H/0107/001
药品名称Bisolangin 20 mg, zuigtabletten
活性成分
    • Ambroxol hydrochloride 20.0 mg
剂型Lozenge
上市许可持有人Opella Healthcare Belgium (handelsnaam Sanofi Belgium) Leonardo da Vincilaan 19 BE-1831 Diegem Belgium
参考成员国 - 产品名称Belgium (BE)
Bisolangin 20 mg lozenge
互认成员国 - 产品名称
    • Sweden (SE)
许可日期2003/12/03
最近更新日期2024/12/12
药物ATC编码
    • R02AD Anesthetics, local
申请类型
  • TypeLevel1:Known Active Substance
  • TypeLevel2:Initial Application
  • TypeLevel3:Full Dossier Article 4.8 Di 65/65
  • TypeLevel4:Chemical Substance
  • TypeLevel5:Non Prescription (including OTC)
附件文件下载
市场状态Positive
©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase